Work

The orexin 1-selective receptor antagonist nivasorexant is a time-dependent inhibitor of CYP2C19 and CYP3A4

Year: 2025

Type: article

Source: Xenobiotica

DOI: 10.1080/00498254.2025.2513321

Authors: Alexander Treiber, Fabienne Drouet, Swen Seeland, Florian Willecke, Jodi T. Williams, Hamed Aissaoui, Benjamin Berger, Stephane Delahaye

Institution: Idorsia Pharmaceuticals Ltd (Switzerland)

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410919293

FWCI: 0.88

Cites: 25

Cited by: 1

Related to: 10